Bio-Rad Laboratories, Inc. (BIO) Revenue by Segment
Bio-Rad Laboratories revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), Bio-Rad Laboratories's largest business segment was Clinical Diagnostics, with $399.00 million or 61% of revenue, up 2.6% from a year earlier. Next: Life Science (39%).
By region, United States brought in 39%, Europe brought in 35% and Asia Pacific brought in 19% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Clinical Diagnostics (+2.6%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.
Bio-Rad Laboratories, Inc.
Revenue breakdown
Fiscal quarters, from company filings
Bio-Rad Laboratories revenue by business segment, last 4 quarters
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Clinical Diagnostics | $399.0M | $363.6M | $391.2M | $388.8M | 61% |
| Life Science | $252.0M | $228.5M | $261.8M | $262.8M | 39% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Bio-Rad Laboratories revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $255.5M | $229.8M | $270.0M | $266.9M | 39% |
| Europe | $229.2M | $206.8M | $222.2M | $217.2M | 35% |
| Asia Pacific | $121.8M | $110.4M | $121.0M | $126.4M | 19% |
| Americas | $44.5M | $45.1M | $39.8M | $41.1M | 7% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
What are Bio-Rad Laboratories's business segments?
Clinical Diagnostics and Life Science (as reported for Q2 fiscal 2026).
Which business segment makes the most money for Bio-Rad Laboratories?
Clinical Diagnostics: $399.00 million, or 61% of revenue, in Q2 fiscal 2026.
Where does Bio-Rad Laboratories make its money?
By region in Q2 fiscal 2026: United States (39%), Europe (35%), Asia Pacific (19%) and Americas (7%).
